SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-236943
Filing Date
2018-08-03
Accepted
2018-08-02 20:20:04
Documents
2
Group Members
ALAN FRAZIERBRIAN MORFITTFHM VII, L.L.C.FHM VII, L.P.FRAZIER HEALTHCARE VII-A, L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 SC 13G d582636dsc13g.htm SC 13G 181308
2 EX-99.1A d582636dex991a.htm EX-99.1A 13885
  Complete submission text file 0001193125-18-236943.txt   197074
Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Healthcare VII, L.P. (Filed by) CIK: 0001553071 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89113 | Film No.: 18990128
SIC: 2834 Pharmaceutical Preparations